Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network
Amoroso, Loredana, Castel, Victoria, Bisogno, Gianni, Casanova, Michela, Marquez-Vega, Catalina, Chisholm, Julia C., Doz, François, Moreno, Lucas, Ruggiero, Antonio, Gerber, Nicolas U., Fagioli, FranVolume:
135
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2020.04.031
Date:
August, 2020
File:
PDF, 552 KB
2020